The prognostic role of a phospho-Stathmin 1 signature in breast cancer treated with neoadjuvant chemotherapy

BACKGROUND: High expression of Stathmin 1 (STMN1) protein is related to a poor prognosis in various tumors, including breast cancer. In our previous study, a phospho-STMN1 signature was conducted to predict outcomes in adjuvantly treated breast cancer patients. This study aimed to explore the relati...

Descripción completa

Detalles Bibliográficos
Autores principales: Xie, Zhen, Zhen, Tiantian, Lin, Ying, Shao, Nan, Kuang, Xiaying
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9742056/
https://www.ncbi.nlm.nih.gov/pubmed/36518803
http://dx.doi.org/10.21037/gs-22-628

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9742056/
https://www.ncbi.nlm.nih.gov/pubmed/36518803
http://dx.doi.org/10.21037/gs-22-628

Ejemplares similares